Skip to main content

Articles

Page 1 of 30

  1. This is an exploratory research of cystoprostatectomy (CP) in treating prostate cancer (PCa) extending to the bladder, which aimed to evaluate the effects of CP on survival outcomes and improving quality of li...

    Authors: Xiaoliang Sun, Min Liu, Yong Zhao, Kang Leng and Haiyang Zhang
    Citation: BMC Urology 2022 22:118
  2. Arterioureteral fistula (AUF) is a rare, life-threatening condition wherein communication occurs between a ureter and the common, internal, or external iliac artery. The sensitivity of common clinical imaging ...

    Authors: Zhiwen Jiang, Jian Wang, Jianfeng Cui, Shouzhen Chen, Sifeng Qu, Wenfu Wang, Hu Guo, Benkang Shi and Yaofeng Zhu
    Citation: BMC Urology 2022 22:117
  3. The need for the left ureter to pass through the subsigmoid during ileal conduit diversion surgery has not been investigated in any studies. A modified technique is simply used in the ileal conduit with the le...

    Authors: Jinyou Wang, Zhouting Tuo, Mingzhu Gao, Jie Min, Yi Wang, Tao Zhang, Dexin Yu and Liangkuan Bi
    Citation: BMC Urology 2022 22:116
  4. MUC1 is a type I transmembrane protein that plays an important role in tumor cell signal transduction. Although current studies have shown that MUC1 is upregulated in bladder cancer (BC), the specific mechanis...

    Authors: Liangliang Qing, Qingchao Li, Yongjin Yang, Wenbo Xu and Zhilong Dong
    Citation: BMC Urology 2022 22:114
  5. Multiple kidney tumours are frequently seen in hereditary syndromes and familial diseases. Renal collision tumours (RCT) are characterized by the simultaneous existence of different and unrelated tumour types ...

    Authors: Valère Belle Mbou, Florian Sanglier, Julia Pestre-Munier, Aurélien Descazeaud and François Labrousse
    Citation: BMC Urology 2022 22:113
  6. Kidney cancer accounts for 2% of new cancers diagnosed in Australia annually. Partial and radical nephrectomy are the treatment of choice for kidney cancer. Nephrectomy is also performed for living donor kidne...

    Authors: Jordan Y. Li, Sarah Bodda, Alex Jay, Ganessan Kichenadasse, Michael Chong, Jonathan M. Gleadle and Michael O’Callaghan
    Citation: BMC Urology 2022 22:112
  7. To develop and validate a preoperative cystoscopic-based predictive model for predicting postoperative high-grade bladder cancer (BCa), which could be used to guide the surgical selection and postoperative tre...

    Authors: Qikai Wu, Lingkai Cai, Baorui Yuan, Qiang Cao, Juntao Zhuang, Meiling Bao, Zhen Wang, Dexiang Feng, Jun Tao, Pengchao Li, Qiang Shao, Xiao Yang and Qiang Lu
    Citation: BMC Urology 2022 22:111
  8. Men diagnosed with localized prostate cancer (PCa) on active surveillance (AS) have shown to cope with anxiety caused by living with an ‘untreated cancer’ and different factors can influence the tolerance level f...

    Authors: Paola Dordoni, Sebastiaan Remmers, Riccardo Valdagni, Lara Bellardita, Letizia De Luca, Fabio Badenchini, Cristina Marenghi, Monique J. Roobol and Lionne D. F. Venderbos
    Citation: BMC Urology 2022 22:110
  9. To report the clinicopathological features and mid- to long-term oncologic results of Xp11.2 translocation/transcription factor E3 (TFE3) gene fusion renal cell carcinomas (Xp11.2 translocation RCCs) in a single ...

    Authors: Jiale Zhou, Ling Zhao, Zhaolin Yang, Yonghui Chen, Xiaorong Wu and Wei Xue
    Citation: BMC Urology 2022 22:109
  10. Muscle-infiltrating urothelial carcinoma of the bladder is the most common genitourinary cancer. Immunotherapeutic agents targeting protein-1 programmed death or protein-1 programmed death ligand are currently...

    Authors: Patrik Palacka, Pavol Janega, Hana Polakova, Jan Slopovsky, Valentina De Angelis and Michal Mego
    Citation: BMC Urology 2022 22:108
  11. The Prostate Imaging Reporting and Data System (PIRADS) has shown promise in improving the detection of Gleason grade group (GG) 2–5 prostate cancer (PCa) and reducing the detection of indolent GG1 PCa. Howeve...

    Authors: Julio Meza, Rilwan Babajide, Ragheed Saoud, Jamila Sweis, Josephine Abelleira, Irene Helenowski, Borko Jovanovic, Scott Eggener, Frank H. Miller, Jeanne M. Horowitz, David D. Casalino and Adam B. Murphy
    Citation: BMC Urology 2022 22:107
  12. The purpose of this study was to characterize the pathophysiological changes of hydronephrosis caused by ureteral calculi obstruction in a new rabbit ureteral calculi model by implanting flowable resin.

    Authors: Hao Su, Heng Liu, Ke Yang, Weiming Chen, Dongbo Yuan, Wei Wang, Guohua Zhu, Bin Hu, Kehua Jiang and Jianguo Zhu
    Citation: BMC Urology 2022 22:105
  13. Kidney stone disease contributes to a significant proportion of routine urological practice and remains a common cause of worldwide morbidity. The main aim of this clinical-pilot study was to investigate the e...

    Authors: Stephen Fôn Hughes, Alyson Jayne Moyes, Kevin Jones, Christopher Bell, Abigail Duckett, Ahmed Moussa and Iqbal Shergill
    Citation: BMC Urology 2022 22:104
  14. Reproducibility is essential for the integrity of scientific research. Reproducibility is measured by the ability of different investigators to replicate the outcomes of an original publication using the same ...

    Authors: Shelby Rauh, Bradley S. Johnson, Aaron Bowers, Daniel Tritz and Benjamin Matthew Vassar
    Citation: BMC Urology 2022 22:102
  15. The incidence of aberrant catheterization into a ureter is extremely low, and there is a 20% chance that the balloon cannot be deflated. Regrettably, the mechanism underlying this complication remains unknown....

    Authors: Peng-Fei Qin, Wan-Zhang Liu, Bin-Bin Yang, Kai-Ning Lu, Jun-Hai Qian, Jia-Sheng Hu and Yue Cheng
    Citation: BMC Urology 2022 22:99
  16. To assess the inter-observer and intra-observer reliability of the magnetic resonance urography (MRU)—upper urinary tract dilation (UUTD) grading system.

    Authors: Zhonghan Zhou, Limin Liao, Xing Li, Xuesheng Wang, Xunhua Li, Hui Zhao, Han Deng, Qinggang Liu, Yi Gao and Huafang Jing
    Citation: BMC Urology 2022 22:97
  17. Systemic Lutetium-177 prostate-specific membrane antigen-617 radioligand therapy (Lu-177-PSMA-617-RLT) is a novel treatment approach in patients suffering from metastasized castration-resistant prostate cancer...

    Authors: Robin Wrenger, Michael Jüptner, Marlies Marx, Yi Zhao, Maaz Zuhayra, Amke Caliebe, Daniar Osmonov and Ulf Lützen
    Citation: BMC Urology 2022 22:96
  18. Several models and markers were developed and found to predict outcome of advanced renal cell carcinoma. This study aimed to evaluate the prognostic value of the ratio of maximum to minimum tumor diameter (ROD...

    Authors: Hongzhe Shi, Chuanzhen Cao, Li Wen, Lianyu Zhang, Jin Zhang, Jianhui Ma, Jianzhong Shou and Changling Li
    Citation: BMC Urology 2022 22:95
  19. It is challenging to perform a tubeless percutaneous nephrolithotomy (PNL) in patients with tract bleeding. The present study was designed to study the safety and efficacy of the 1470 nm laser for hemostatic c...

    Authors: Huihui Zhang, Hanfeng Xu, Kuilin Fei, Dayong Guo and Youjun Duan
    Citation: BMC Urology 2022 22:94
  20. Staghorn stones require surgical treatment to prevent serious complications. Multitract percutaneous nephrolithotomy (PNL) causes great renal parenchymal injury and blood loss. One-stage endoscopic combined i...

    Authors: Zhi-Hao Chen, Kau-Han Lee, Wen-Hsin Tseng, Chia-Cheng Su, Kun-Lin Hsieh, Chye-Yang Lim and Steven K. Huang
    Citation: BMC Urology 2022 22:93
  21. To investigate the effects of the U.S. Preventive Services Task Force’s (USPSTF) 2012 recommendation against prostate-specific antigen (PSA)-based screening for prostate cancer on survival disparities based on...

    Authors: Isaac E. Kim Jr, Daniel D. Kim, Sinae Kim, Shuangge Ma, Thomas L. Jang, Eric A. Singer, Saum Ghodoussipour and Isaac Yi Kim
    Citation: BMC Urology 2022 22:91
  22. PD-L1 and B7-H3 have been found to be overexpressed in urothelial carcinoma (UC) of the urinary bladder. Recent studies have also demonstrated that B7-H3 and PD-L1 can promote resistance to platinum-based drug...

    Authors: Ahmed M. Mahmoud, Igor Frank, Jacob J. Orme, Roxane R. Lavoie, Prabin Thapa, Brian A. Costello, John C. Cheville, Sounak Gupta, Haidong Dong and Fabrice Lucien
    Citation: BMC Urology 2022 22:90
  23. The effects of the COVID-19 pandemic on healthcare in Australia have yet to be fully determined. There are well documented decreases in the rates of screening and diagnostic testing for many cancers in 2020, w...

    Authors: Anika Jain, James Macneil, Lawrence Kim and Manish I. Patel
    Citation: BMC Urology 2022 22:88
  24. Active surveillance (AS) is the preferred treatment for patients with very low-and low-risk prostate cancer (PCa), but it is underperformed worldwide. This study aimed to report knowledge, attitudes, and pract...

    Authors: Marcelo Langer Wroclawski, Breno Santos Amaral, Paulo Priante Kayano, Wilson Francisco Schreiner Busato Jr, Sebastião José Westphal, Erik Montagna, Bianca Bianco, Andrey Soares, Fernando Cotait Maluf, Gustavo Caserta Lemos and Arie Carneiro
    Citation: BMC Urology 2022 22:86
  25. The insertion of a ureteral access sheath (UAS) is a frequent procedure during flexible ureteroscopy (fURS) to facilitate kidney stone treatment. The aim of this study was to investigate the influence of 12/14...

    Authors: Tomasz Ozimek, Judith R. Wiessmeyer, Julian P. Struck, Marie C. Roesch, Nils Gilbert, Jan M. Laturnus, Axel S. Merseburger and Mario W. Kramer
    Citation: BMC Urology 2022 22:84
  26. The mean number of emergency department visits for all-cause traumas has declined significantly during the COVID-19 pandemic. We aim to identify how a global pandemic and social distancing could affect the tr...

    Authors: Behnam Nabavizadeh, Nizar Hakam, Behzad Abbasi, Nathan M. Shaw and Benjamin N. Breyer
    Citation: BMC Urology 2022 22:83
  27. To observe and explore the effect of metformin on the migration and proliferation of bladder cancer T24 and 5637 cells in vitro.

    Authors: Zhiyong Shen, Dong Xue, Kun Wang, Facai Zhang, Jiaqi Shi, Benzhong Jia, Dan Yang, Qianjin Zhang, Shuai Zhang, Hongyu Jiang, Daiqin Luo, Xueying Li, Quliang Zhong, Junhao Zhang, Zheng Peng, Yu Han…
    Citation: BMC Urology 2022 22:79
  28. At present, there are few studies on renal pelvic transitional cell carcinoma (RPTCC) in elderly patients in the literature. The study aims to establish a new nomogram of cancer-specific survival (CSS) in elde...

    Authors: Jinkui Wang, Jie Tang, Xiaozhu Liu and Dawei He
    Citation: BMC Urology 2022 22:78
  29. To assess the price range in which fexapotide triflutate (FT), a novel injectable, is cost-effective relative to current oral pharmacotherapy (5 α-reductase inhibitor, α-blocker, 5 α-reductase inhibitor and α-blo...

    Authors: Yifan Wei, Joel W. Hay, Alan R. Hay and Sze-chuan Suen
    Citation: BMC Urology 2022 22:76
  30. In patients experiencing disease recurrence after radical cystectomy (RC) for bladder cancer, data about the impact of clinicopathologic factors, including salvage treatment using cytotoxic chemotherapy, on th...

    Authors: Dai Koguchi, Kazumasa Matsumoto, Masaomi Ikeda, Yoshinori Taoka, Takahiro Hirayama, Yasukiyo Murakami, Takuji Utsunomiya, Daisuke Matsuda, Norihiko Okuno, Akira Irie and Masatsugu Iwamura
    Citation: BMC Urology 2022 22:75
  31. Adrenal incidentalomas (AIs) are masses > 1 cm found incidentally during radiographic imaging. They are present in up to 4.4% of patients undergoing CT scan, and incidence is increasing with usage and sensitiv...

    Authors: David Zekan, Robert Scott King, Ali Hajiran, Apexa Patel, Samuel Deem and Adam Luchey
    Citation: BMC Urology 2022 22:73
  32. The advantages and disadvantages of transperineal and transrectal biopsies remain controversial in the era of prostate targeted biopsy. In this study, we compared the cancer detection and complication rates of...

    Authors: Po-Fan Hsieh, Tian-You Chang, Wei-Ching Lin, Han Chang, Chao-Hsiang Chang, Chi-Ping Huang, Chi-Rei Yang, Wen-Chi Chen, Yi-Huei Chang, Yu-De Wang, Wen-Chin Huang and Hsi-Chin Wu
    Citation: BMC Urology 2022 22:72

Affiliated with

  • BMC Urology works with with Cochrane Urology in providing our authors with expert advice on systematic reviews and meta-analyses

Annual Journal Metrics

  • Citation Impact
    2.090 - 2-year Impact Factor (2021)
    2.317 - 5-year Impact Factor (2021)
    1.071 - SNIP (Source Normalized Impact per Paper)
    0.552 - SJR (SCImago Journal Rank)

    Speed
    52 days to first decision for all manuscripts (Median)
    154 days to first decision for reviewed manuscripts only (Median)

    Usage 
    996,210 downloads (2021)
    611 Altmetric mentions (2021)

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal